Clinical Trials and Research News Weekly Roundup | 02-03-2020 S2 E05

Feb 3, 2020 | Digital Media, Video, Weekly Roundup

Youtube TrialSite News Weekly Roundup

AI Giants Increasingly Tap Into & Access Provider Patient Data.

Penn State Rockstar: Madison Evans Represents the Future and We Like It.

The ‘Inland Empire’ Cellular Manufacturing Breakthrough as UC Riverside Licenses Patented IP to Startup.

A Different Kind of Drug Company? Startup EQRx Raises $200m in A Round.

GeneTx and Ultragenyx Announce Investigational New Drug (IND) Application Active for GTX-102 in Patients with Angelman Syndrome.

Genentech’s Risdiplam Meets Primary Endpoint in Pivotal FIREFISH Trial in Infants with Type 1 Spinal Muscular Atrophy.

San Mateo County Health System $57m Shortfall will Face Severe Cuts Impacting Care.

Unity Point Health St. Luke’s Leads Clinical Trial Targeting Chronic Heart Failure Sees Positive Results.

Verily (part of Google Family) Receives FDA 510k Approval for Study Watch with Irregular Pulse Monitor.

Cleveland Clinic Lerner Research Institute Leads Study Identifying New Drug Target for Glioblastoma.

Broad Institute’s Drug Re-purposing Lab Key for Compelling Study Identifying Nearly Fifty Non-Oncology Drugs that May Fight Cancer.

University of Manchester & Other Research Sites Partner with UK’s James Hull for Cancer Survival Study.

University of North Carolina At Chapel Hill-Led Research Pursues Final HIV Cure.

Breakthrough Sheba Medical Center-Originated Cell Therapy Leads to Rejuvenation of Kidney.

Back to the Future: Insight Institute of Neurosurgery and Neurosciences Doing Exciting Things in Flint, MI.

AI 00:32



CANCER 06:32

HIV 07:51

KIDNEY 08:56



Pin It on Pinterest